Treating Nightmares in Posttraumatic Stress Disorder With Clonidine and Doxazosin
Status:
Recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
This randomized controlled trial will test the hypothesis that oral Clonidine or Doxazosin
improves nightmares (primary outcome), other PTSD symptoms and psychopathology (secondary
outcomes) to a greater extent than placebo over a ten week intervention phase in a parallel
group design.